China

Home / China / Latest

Sinopharm applies for vaccine market approval

chinadaily.com.cn | Updated: 2020-11-25 14:29

Share

Share - WeChat

A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co Ltd (Sinopharm) in Beijing, capital of China, April 10, 2020. [Photo/Xinhua]

Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.

Photo

Hunan's smoked fish and meat arrive in time for Spring Festival

Trains undergo inspections ahead of Spring Festival travel rush

Ten photos from across China: Jan 23 – 29

Yunnan's white plum blossoms create a cozy counter to the seasonal chill

Domestic drugmakers take center stage in development, innovation

Shanghai Science and Technology Museum set to reopen after nearly three-year renovation

Latest

State Council News

2026 Share your views on China's finance

Exclusive

Shing-Tung Yau: We aim to cultivate interdisciplinary talent

Beijing West Railway Station marks 30th anniversary

Taiwan compatriots will see more opportunities

Newsmaker

He Jiaolong's story included in Xinjiang's government work report

Writer's quest to record Beijing's fading memories

Ten photos you don't wanna miss

Ten photos from across China: Jan 23 – 29

Special Coverage

Live: Hong Kong residential area fire

4th Plenary Session of the 20th CPC Central Committee

BACK TO THE TOP

English

中文

Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349

About China Daily

Advertise on Site

Expat Employment

FOLLOW US